“merck” Archives

in
Entry Author Date Location
Notes From The JPM ’17 Vortex: Trump, Rainstorms & The Price You Pay 01/13/17 National
Manufacturing Issues Stall Tesaro Cancer Nausea Drug at FDA 01/12/17 Boston
Vertex Deals Cancer Drugs to Merck for $230M, Staying True to Plan 01/11/17 Boston
At Allergan And Other Pharmas, Price Transparency Has Limits 01/11/17 National
Pain Drug Developer Adynxx Picks Up $16M for Another Clinical Trial 01/10/17 San Francisco
First Trial Underway, Jounce Preps IPO To Fund Immuno-Oncology Work 01/03/17 Boston
14 For ’17: Key Clinical Data to Watch For Next Year (Part 1) 12/21/16 National
Biogen Promotes Vounatsos to CEO, Capping Scangos’s 6-Year Run 12/19/16 Boston
ASH Roundup: CAR-T Shuffle, Hemophilia Updates, Checkpoint Progress & More 12/06/16 National
Bio Roundup: CAR-T Ups & Downs, Lilly’s Failure, Myeloma & More 12/02/16 National
With Reverse Merger, Miragen to Go Public, Get $40M Boost From Investors 11/01/16 Boulder/Denver
Third Rock Gets $616M to Grow New Crop of Biotech Startups 10/31/16 Boston
Bio Roundup: Drug Pricing, Cystic Fibrosis Showdown, Myovant & More 10/28/16 National
FDA: Keytruda Now OK For Some Patients With Untreated Lung Cancer 10/25/16 National
Eli Lilly Commits $15M More to Seattle Institute’s TB Drug Search 10/18/16 Indiana
Bio Roundup: Bristol & Illumina Blues, Sickle Cell News & More 10/14/16 National
Checkpoints In Lung Cancer, and Other Oncology News From Europe 10/11/16 National
Taking Aim at Alexion, Ra Pharma Heads to IPO Queue 10/03/16 Boston
New Rockefeller Prez Takes Stock of “Wildly Underdeveloped” NY Bio Scene 09/27/16 New York
Immunotherapy Clinical Tests Spur Hope, and Plenty of Headaches 09/07/16 National
Filing: Moderna Blowing Past Record $450M Round With New $600M Raise 08/29/16 Boston
Pfizer Shells Out $14B to Win Medivation Sweepstakes 08/22/16 San Francisco
War, Surgery, and Cancer Vaccines: Meet San Antonio’s George Peoples 08/19/16 Texas
As Pfizer Buys, Closes Bind Tx, CEO Hirsch Heads to Agios 08/16/16 Boston
MIT’s Jacks Leans on Disney Family, Not VCs, to Hatch New Startup 08/11/16 Boston
Heron Gains FDA Support For Nausea Drug After A Year Under Review 08/10/16 San Francisco
Merck Surges As Bristol’s Immunotherapy Drug Stumbles in Lung Cancer 08/05/16 Boston
Biotech Roundup: Biogen Rumors, Theranos, Electro-Drugs & More 08/05/16 National
In a Microbiome Setback, Seres Drug Fails in Phase 2, Shares Crushed 07/29/16 Boston
With $40M Bid, Pfizer Set to Buy, And Close, Bankrupt Bind Tx 07/27/16 Boston
Page 1 of 20 next page »